Shindo, Tetsuya <br/><br/>
Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Apr 2019 
 - 1491-1496 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-018-4521-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Carnitine--therapeutic use<br/>Dietary Supplements<br/>Fatigue--chemically induced<br/>Female<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mind-Body Therapies<br/>Pilot Projects<br/>Sunitinib--adverse effects<br/>Surveys and Questionnaires<br/>Treatment Outcome